KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Net Income: 2010-2025

Historic Net Income for TherapeuticsMD (TXMD) over the last 15 years, with Sep 2025 value amounting to $102,000.

  • TherapeuticsMD's Net Income rose 342.86% to $102,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $229,000, marking a year-over-year decrease of 64.82%. This contributed to the annual value of $131,000 for FY2024, which is 105.08% up from last year.
  • Latest data reveals that TherapeuticsMD reported Net Income of $102,000 as of Q3 2025, which was up 1,600.00% from $6,000 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Net Income registered a high of $127.2 million during Q2 2022, and its lowest value of -$47.4 million during Q3 2021.
  • Moreover, its 3-year median value for Net Income was -$17,000 (2025), whereas its average is -$433,727.
  • As far as peak fluctuations go, TherapeuticsMD's Net Income spiked by 398.12% in 2022, and later slumped by 122.67% in 2025.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Net Income stood at $50.1 million in 2021, then crashed by 41.68% to $29.2 million in 2022, then tumbled by 97.75% to $658,000 in 2023, then plummeted by 79.03% to $138,000 in 2024, then skyrocketed by 342.86% to $102,000 in 2025.
  • Its Net Income was $102,000 in Q3 2025, compared to $6,000 in Q2 2025 and -$17,000 in Q1 2025.